TLR4 and neoplasm: In addition, lentinan can activate immune cells to fight cancer and tumor through a variety of signaling pathways, such as TLR4/Dectin1-MAPK, Syk-PKC-NFκB and TLR4-PI3K/AKT-NF-κB pathways [14].